Real-time enrollment status for this atopic dermatitis clinical trial
Current Status
Completed
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT06309355 |
| Recruiting Status | Completed |
| Condition | Atopic Dermatitis |
| Phase | Clinical Trial |
| Target Enrollment | 36 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Hangzhou Yirui Pharmaceutical Technology Co., Ltd |
| Last Updated on CT.gov | December 18, 2025 (Dec 18, 2025) |
As of March 2, 2026: Clinical trial NCT06309355 is currently completed participants. This clinical trial study for atopic dermatitis is not currently accepting new participants at 4 locations across the United States. The study is sponsored by Hangzhou Yirui Pharmaceutical Technology Co., Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06309355 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06309355 was last updated Dec 18, 2025 (December 18, 2025). HelloStudys verifies this status automatically.